Mindfulness Based Relapse Prevention Therapy in Individuals with Amphetamine Use Disorder

Self funded0 个研究点目标入组 90 人开始时间: 待定最近更新: 2021年6月21日

试验速览

暂无简介。

•Age between 18 and 40 years age and therefore legally eligible to consent.
•A history of use of methamphetamine and a diagnosis of stimulant use disorder as described in the Mental Disorders Diagnostic and Statistical Manual (DSM-5); the passage of more than a week from complete methamphetamine detoxification and negative urine test.
•Be able to speak and read Urdu, sign a written consent for the participants to take part in the study, be mindful. Apart from signing into a written agreement, they have their rights, including the protection of personal data, the immunity to physical or mental harm, and the possibility of quitting the study they wish.
•All participants would go through urinalysis to make sure that they are not intoxicated

•Unwilling to attend the meetings, absenteeism of more than two sessions, engage concurrently in other health services, and have a long-term dependency on multi-drug concurrently;
•Requisite medical detoxification from any substances
•Those are suffering from severe medical and neuropsychiatric complications or any psychotic illness at the time of screening for intake
•Participants those are unavailable or hesitant to be a part of the study for the 20 weeks
•An individual having a history of using illicit substance use (e.g. cocaine, heroin)
•Already completed MBRP sessions.

发起方

Self funded